• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物基因组学实施:选择参考实验室的考虑因素。

Pharmacogenomics Implementation: Considerations for Selecting a Reference Laboratory.

机构信息

Department of Pharmacotherapeutics and Clinical Research, College of Pharmacy, University of South Florida, Tampa, Florida.

Personalized Medicine Program, Mission Health, Asheville, North Carolina.

出版信息

Pharmacotherapy. 2017 Sep;37(9):1014-1022. doi: 10.1002/phar.1985. Epub 2017 Sep 3.

DOI:10.1002/phar.1985
PMID:28699700
Abstract

One of the initial steps for implementing pharmacogenomics into routine patient care is selecting an appropriate clinical laboratory to perform the testing. With the rapid advances in genotyping technologies, many clinical laboratories are now performing pharmacogenomic testing. Selection of a reference laboratory depends on whether a particular genotype assay is already performed by an internal health care organization laboratory or only available externally. Other factors for consideration are coverage of genomic variants important for the patient population, technical support, and cost. In some instances, the decision to select a particular reference laboratory may be the responsibility of the clinician who is recommending genomic interrogation. Only limited guidance is available that describes the laboratory characteristics to consider when selecting a reference laboratory. We provide practical considerations for selecting a clinical laboratory for pharmacogenomic testing broadly categorized into four domains: pharmacogene and variant selection; logistics; reporting of results; and test costs along with reimbursement.

摘要

将药物基因组学纳入常规患者护理的初始步骤之一是选择合适的临床实验室来进行检测。随着基因分型技术的快速发展,许多临床实验室现在都在进行药物基因组学检测。参考实验室的选择取决于特定基因型检测是由内部医疗保健组织实验室进行还是仅外部可用。其他需要考虑的因素包括对患者群体重要的基因组变异的覆盖范围、技术支持和成本。在某些情况下,选择特定参考实验室的决定可能由建议进行基因组检测的临床医生负责。目前只有有限的指南描述了选择参考实验室时需要考虑的实验室特征。我们提供了用于选择药物基因组学检测临床实验室的实用考虑因素,大致分为四个领域:药物基因和变体选择;物流;结果报告;以及测试成本和报销。

相似文献

1
Pharmacogenomics Implementation: Considerations for Selecting a Reference Laboratory.药物基因组学实施:选择参考实验室的考虑因素。
Pharmacotherapy. 2017 Sep;37(9):1014-1022. doi: 10.1002/phar.1985. Epub 2017 Sep 3.
2
DPYD Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, American College of Medical Genetics and Genomics, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, Pharmacogenomics Knowledgebase, and Pharmacogene Variation Consortium.DPYD基因分型建议:分子病理学协会、美国医学遗传学与基因组学学会、临床药物基因组学实施联盟、美国病理学家学会、荷兰皇家药剂师协会荷兰药物基因组学工作组、欧洲药物基因组学与个性化治疗学会、药物基因组学知识库以及药物基因变异联盟的联合共识建议
J Mol Diagn. 2024 Oct;26(10):851-863. doi: 10.1016/j.jmoldx.2024.05.015. Epub 2024 Jul 18.
3
Advancing Pharmacogenomics from Single-Gene to Preemptive Testing.推进单基因检测向药物基因组学预测性检测的发展。
Annu Rev Genomics Hum Genet. 2022 Aug 31;23:449-473. doi: 10.1146/annurev-genom-111621-102737. Epub 2022 May 10.
4
Integrating pharmacogenomics into electronic health records with clinical decision support.将药物基因组学与临床决策支持系统整合到电子健康记录中。
Am J Health Syst Pharm. 2016 Dec 1;73(23):1967-1976. doi: 10.2146/ajhp160030.
5
A Tutorial for Pharmacogenomics Implementation Through End-to-End Clinical Decision Support Based on Ten Years of Experience from PREDICT.基于PREDICT十年经验的通过端到端临床决策支持实施药物基因组学教程
Clin Pharmacol Ther. 2021 Jan;109(1):101-115. doi: 10.1002/cpt.2079. Epub 2020 Nov 15.
6
Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward.标准化可加速药物基因组学的应用:现状与未来之路
Pharmacogenomics. 2018 Jul 1;19(10):847-860. doi: 10.2217/pgs-2018-0028. Epub 2018 Jun 19.
7
The challenges of implementing pharmacogenomic testing in the clinic.在临床中实施药物基因组学检测的挑战。
Expert Rev Pharmacoecon Outcomes Res. 2017 Dec;17(6):567-577. doi: 10.1080/14737167.2017.1385395. Epub 2017 Oct 3.
8
Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol.个体化医学的预先基因分型:利用基因组数据制定正确的药物、正确的剂量、正确的治疗方案以实现个体化治疗。
Mayo Clin Proc. 2014 Jan;89(1):25-33. doi: 10.1016/j.mayocp.2013.10.021.
9
The Daniel K. Inouye College of Pharmacy Scripts: Precision Medicine Through the Use of Pharmacogenomics: Current Status and Barriers to Implementation.丹尼尔·K·伊努耶药学院文稿:通过药物基因组学实现精准医学:现状与实施障碍
Hawaii J Med Public Health. 2017 Sep;76(9):265-269.
10
Costing Methods as a Means to Measure the Costs of Pharmacogenomics Testing.成本计算方法作为衡量药物基因组学检测成本的手段。
J Appl Lab Med. 2020 Sep 1;5(5):1005-1016. doi: 10.1093/jalm/jfaa113.

引用本文的文献

1
Clinician Experiences at the Frontier of Pharmacogenomics and Future Directions.临床医生在药物基因组学前沿的经验与未来方向
J Pers Med. 2025 Jul 7;15(7):294. doi: 10.3390/jpm15070294.
2
Pharmacists' perspectives on integrating pharmacogenetics in clinical practice.药剂师对将药物遗传学整合到临床实践中的看法。
Hum Genomics. 2025 Jun 25;19(1):71. doi: 10.1186/s40246-025-00780-3.
3
Progress in Pharmacogenomics Implementation in the United States: Barrier Erosion and Remaining Challenges.美国药物基因组学实施进展:障碍消除与尚存挑战
Clin Pharmacol Ther. 2025 Oct;118(4):778-789. doi: 10.1002/cpt.3736. Epub 2025 Jun 4.
4
Survey of the utilization of genotype-guided tacrolimus management in United States solid organ transplant centers.美国实体器官移植中心基因型指导下他克莫司管理的应用调查。
Pharmacogenomics. 2025 Feb-Mar;26(3-4):89-94. doi: 10.1080/14622416.2025.2489920. Epub 2025 Apr 9.
5
A Guide for Implementing DPYD Genotyping for Systemic Fluoropyrimidines into Clinical Practice.将二氢嘧啶脱氢酶(DPYD)基因分型用于全身氟嘧啶类药物的临床实践实施指南。
Clin Pharmacol Ther. 2025 May;117(5):1194-1208. doi: 10.1002/cpt.3567. Epub 2025 Jan 31.
6
Comparing commercial pharmacogenetic testing results and recommendations for antidepressants with established CPIC guidelines.将商业药物遗传学检测结果以及抗抑郁药的建议与既定的CPIC指南进行比较。
Front Pharmacol. 2024 Nov 25;15:1500235. doi: 10.3389/fphar.2024.1500235. eCollection 2024.
7
Time trends and patterns in opioid prescription use following orthopaedic surgery in Ontario, Canada, from 2004/2005 to 2017/2018: a population-based study.加拿大安大略省 2004/2005 年至 2017/2018 年骨科手术后阿片类药物处方使用的时间趋势和模式:一项基于人群的研究。
BMJ Open. 2023 Nov 14;13(11):e074423. doi: 10.1136/bmjopen-2023-074423.
8
Pharmacogenomics in practice: a review and implementation guide.实践中的药物基因组学:综述与实施指南。
Front Pharmacol. 2023 May 18;14:1189976. doi: 10.3389/fphar.2023.1189976. eCollection 2023.
9
A national survey of individualized pharmaceutical care practice in Chinese hospitals in 2019.2019年中国医院个体化药学服务实践的全国性调查。
Front Pharmacol. 2023 Mar 2;14:1022134. doi: 10.3389/fphar.2023.1022134. eCollection 2023.
10
How to Implement a Pharmacogenetics Service at your Institution.如何在您的机构开展药物遗传学服务。
J Am Coll Clin Pharm. 2022 Nov;5(11):1161-1175. doi: 10.1002/jac5.1699. Epub 2022 Aug 27.